(UroToday.com) In a plenary presentation in the Navigating Uncertain Times in Muscle-Invasive and Advanced Bladder Cancer session at the 2021 American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU), Dr. Apolo discussed uncertainties in the timing and sequence of therapies for patients with metastatic bladder cancer, emphasizing recent data, new approvals, and ongoing studies of emerging approaches.